Chemical Testing Program Sample Clauses

Chemical Testing Program. The scope of work for this project included chemical testing of soil from the boreholes to assist in selection of disposal options for excess soils that may be generated through construction. Accordingly, nine (9) soil samples including one (1) duplicate from the boreholes and one (1) soil sample from a granular stockpile noted on site were submitted for bulk chemical testing. The samples were analyzed for minimum sampling requirements outlined in O. Reg. 406/19 for metals, hydride-forming metals, electrical conductivity (EC), sodium adsorption ratio (SAR), benzene, toluene, ethyl benzene and xylene (collectively ‘BTEX’) and petroleum hydrocarbons (PHC) in accordance with the Ministry of the Environment, Conservation and Parks (MECP) document “Rules For Excess Soil Management And Excess Soil Quality Standards” covered under O.Reg.406/19. One (1) of the samples from the boreholes was also tested for Sulphate to assess potential for sulphate attack on subsurface concrete. In addition, three (3) selected soil samples were subjected to the modified Synthetic Precipitation Leaching Procedure (‘mSPLP’) analysis for metals covered under O.Reg.406/19. Since these samples were submitted to the analytical laboratory under one (1) chain of custody, the Certificate of Analysis cannot be separated to reflect only those samples from the Proposed Building 1 portion of the site. As such, the test results are discussed for all samples submitted for analysis. As of January 1, 2021, the foregoing testing program represents the testing most commonly required by private receiving sites requiring fill for site grading purposes. The soil samples were submitted to an independent laboratory accredited by the Canadian Association for Laboratory Accreditation (CALA). Sample location and analytical data are summarized in the following table. The results of the chemical testing (Certificates of Analysis) are compiled in Appendix B attached. Test results were compared to the applicable tables in the MECP document “Soil Ground Water and Sediment Standards for Use Under Part XV.1 of the Environmental Protection Act” – April 15, 2011 in accordance with O.Reg.153/04 as amended and the “Rules For Excess Soil Management And Excess Soil Quality Standards” in accordance with O.Reg.406/19. Sample ID Location Depth (m) Material Matrix Analytical Parameters BH1 SS2 Borehole 1 0.8 to 1.2 Native Clayey Silt Till Metals, EC, SAR, BTEX, PHC, mSPLP (Metals) BH4 SS3 Borehole 4 1.5 to 1.9 Fill Metals, E...
View Source

Related to Chemical Testing Program

  • Random Drug Testing All employees covered by this Agreement shall be subject to random drug testing in accordance with Appendix D.

  • Human Leukocyte Antigen Testing This plan covers human leukocyte antigen testing for A, B, and DR antigens once per member per lifetime to establish a member’s bone marrow transplantation donor suitability in accordance with R.I. General Law §27-20-36. The testing must be performed in a facility that is: • accredited by the American Association of Blood Banks or its successors; and • licensed under the Clinical Laboratory Improvement Act as it may be amended from time to time. At the time of testing, the person being tested must complete and sign an informed consent form that also authorizes the results of the test to be used for participation in the National Marrow Donor program.

  • Drug Testing (A) The state and the PBA agree to drug testing of employees in accordance with section 112.0455, F.S., the Drug-Free Workplace Act. (B) All classes covered by this Agreement are designated special risk classes for drug testing purposes. Special risk means employees who are required as a condition of employment to be certified under Chapter 633 or Chapter 943, F.S. (C) An employee shall have the right to grieve any disciplinary action taken under section 112.0455, the Drug-Free Workplace Act, subject to the limitations on the grievability of disciplinary actions in Article 10. If an employee is not disciplined but is denied a demotion, reassignment, or promotion as a result of a positive confirmed drug test, the employee shall have the right to grieve such action in accordance with Article 6.

  • Laboratory Testing All laboratories selected by UPS Freight for analyzing Controlled Substances Testing will be HHS certified.

  • Product Testing No later than [**] prior to a scheduled Delivery ARIAD US shall send to ARIAD SWISSCO the Delivery Documents for review. Following such review, unless within [**] of receipt of the Delivery Documents ARIAD SWISSCO gives written notice of rejection of the Product to be delivered, stating the reasons for such rejection, the Delivery shall proceed, and both Parties shall organize the same. Upon arrival at ARIAD SWISSCO nominated site it shall visually inspect the shipment of the Product to identify any damage to the external packaging. ARIAD SWISSCO may reject any shipment (or portion thereof) of the Product that is damaged by providing to ARIAD US reasonable evidence of damage within [**] after Delivery of such Product. If ARIAD SWISSCO does not so reject any shipment (or portion thereof) of the Product within [**] of Delivery of such Product, ARIAD SWISSCO shall be deemed to have accepted such shipment of the Product; provided, however, that in the case of the Product having any Latent Defect, ARIAD SWISSCO shall notify ARIAD US promptly once it becomes aware that a Product contains a Latent Defect and subsequently may reject such Product by giving written notice to ARIAD US of ARIAD SWISSCO’s rejection of such Product and shipping a representative sample of such Product or other evidence of Non-Conformance to ARIAD US within [**] after becoming aware of such Latent Defect, which notice shall include a description of the Latent Defect.